Research Roundup: What we’re reading this week
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
The World Medical Association has adopted and published a revised version of the Declaration of Helsinki, which sets standards regarding medical research involving human subjects. The changes reflect a call to increase protection for people taking part in medical research.
GHTC member Aeras and the Statens Serum Institut have initiated a new clinical study for a candidate tuberculosis (TB) vaccine. In related news, GHTC member the Global Health Innovation and Technology (GHIT) Fund announced that it will invest $720,000 for early work on a novel vaccine candidate against TB being co-developed by Japan’s Create Vaccine Co., Ltd. and Aeras.
The Kaiser Family Foundation released a new public opinion survey on the US role in global health. The survey finds that Americans’ basic level of support for current levels of US spending on efforts to improve health for people in developing countries has held relatively steady in recent years.
GHTC member the International AIDS Vaccine Initiative (IAVI) has released its 2012 annual progress report, which details IAVI’s progress, accomplishments, and key partnerships over the past year.
The White House's Office of Management and Budget (OMB) recently confirmed that sequestration has drained about $85 million in user fees from the US Food and Drug Administration. The cuts are expected to continue, according to an OMB response to Rep. Anna Eshoo (D-CA), which she released this week.
GHTC member TB Alliance has entered into a collaboration with Svizera Europe, one of the leading global supply and distribution companies for TB treatments. The partnership aims to create and enable access to new medicines for childhood TB.